Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Gisadenafil besylate

😃Good
Catalog No. T11400Cas No. 334827-98-4
Alias UK 369003-26

Gisadenafil besylate (UK 369003-26) is a specific, orally active phosphodiesterase 5 (PDE5) inhibitor that prevents the degradation of cyclic guanosine monophosphate (cGMP) with an IC50 of 3.6 nM.

Gisadenafil besylate

Gisadenafil besylate

😃Good
Catalog No. T11400Alias UK 369003-26Cas No. 334827-98-4
Gisadenafil besylate (UK 369003-26) is a specific, orally active phosphodiesterase 5 (PDE5) inhibitor that prevents the degradation of cyclic guanosine monophosphate (cGMP) with an IC50 of 3.6 nM.
Pack SizePriceAvailabilityQuantity
25 mg$6838-10 weeks
50 mg$8888-10 weeks
100 mg$1,3408-10 weeks
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Gisadenafil besylate (UK 369003-26) is a specific, orally active phosphodiesterase 5 (PDE5) inhibitor that prevents the degradation of cyclic guanosine monophosphate (cGMP) with an IC50 of 3.6 nM.
Targets&IC50
PDE1A:9.1 μM, PDE5A:3.6 nM
In vitro
The IC50 of Gisadenafil for PDE5A is 3.6 nM. In contrast, the IC50 of Gisadenafil for PDE1A is 9.1 μM, an approximately 2500-fold difference in specificity.Since some PDE5 inhibitors can also interact with PDE1 isotypes found within the cerebral vasculature, the specificity of Gisadenafil for PDE5 is confirmed.?This is directly tested with recombinant PDE5A and PDE1A overexpressed in COS-7 cells.
In vivo
Gisadenafil also restores the dilation of small (<25 μm) arterioles following hypercapnia, although it fails to restore full dilation of larger (>25 μm) vessels.
AliasUK 369003-26
Chemical Properties
Molecular Weight677.79
FormulaC29H39N7O8S2
Cas No.334827-98-4
Relative Density.1.31g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Gisadenafil besylate | purchase Gisadenafil besylate | Gisadenafil besylate cost | order Gisadenafil besylate | Gisadenafil besylate chemical structure | Gisadenafil besylate in vivo | Gisadenafil besylate in vitro | Gisadenafil besylate formula | Gisadenafil besylate molecular weight